All In MedTech

Device Trial Radar · NCT02155790

The Peregrine Study: A Safety and Performance Study of Renal Denervation

A Safety and Performance Study of Renal Denervation by Neurolysis Using the Ablative Solutions Inc. Peregrine System™ Infusion Catheter

Last checked: Nov 19, 2026Latest source record: Jun 14, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

10

Actual

Start

Jul 2014

Primary completion

Jan 2016

Study completion Sep 4, 2017

Sponsor

Lead sponsor
Ablative Solutions, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 4, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Ablative Solutions, Inc. Peregrine System Infusion Catheter is a catheter-based device which is intended to be used to ablate the afferent and efferent sympathetic nerves serving the kidneys. The catheter is typically inserted via the femoral artery, steered into the renal artery, and then delivers, by infusion from its distal end, a neurolytic agent. This targets the nerve bundles, which are in the adventitia - a sheath surrounding the artery. The aim is to reduce blood pressure in cases of resistant hypertension - seriously elevated blood pressure which does not respond to drug treatment.

Conditions

  • Hypertension

Interventions

  • The Peregrine System Infusion CatheterDevice

    The ASI catheter is inserted bilaterally into the renal arteries and a specified amount of a neurolytic agent is inserted into the vessel walls.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Vessel dissection or perforationTime frame: Immediate post procedure
  2. Grade 3 or Grade 4 hemorrhageTime frame: During or immediately after procedure
  3. Cerebrovascular accidentTime frame: Time of procedure

3 more outcomes with a free account

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Na Homolce Hospital

    Prague, Czechia

  • American Heart of Poland

    Tychy, Poland

  • American Heart of Poland

    Ustroń, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.